A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

A new at-home saliva test could ... as an elevated PSA level can indicate a prostate issue but not necessarily prostate cancer. The new saliva tests analyze DNA, looking for a range of small ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

A new form of focal therapy for prostate cancer has made its way to the Natural State, set to be offered by the University of ...

SYNLAB Nigeria, a leader in medical diagnostics, is at the forefront of this critical process, ensuring that individuals and ...

Given the opportunity to screen for prostate cancer with a prostate-specific antigen (PSA) test, a significant number of ...

The accuracy of a test depends on a number of factors, including the range of normal ... such as a prostate-specific antigen (PSA) for prostate cancer, false results can be more difficult to ...

Given the opportunity to screen for prostate cancer with a prostate-specific antigen (PSA) test, a significant number ... and 20 years of follow-up. The results indicate that roughly 1 in 6 ...

This randomized, double-blind, placebo-controlled Phase III trial was designed to test the efficacy ... of-study biopsy if serum PSA levels fell within a prespecified range. Prostate cancer ...

A new business in Lower Paxton Township is looking to help treat men’s health issues. Gameday Men’s Health might sound like ...

Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Wednesday, April 16th, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.